Related Experiment Video
Updated: Jan 17, 2026

Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags
Published on: January 17, 2019
Rational discovery of molecular glue degraders based on block chemistry
Junjie Wei1, Wenjing Feng2, Qingsong Chen1
1Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013 Hunan, China; Hunan Key Laboratory of Small Molecules for Diagnosis and Treatment of Chronic Disease, Changsha 410013 Hunan, China; Hunan Key Laboratory of Organ Fibrosis, Changsha 410013 Hunan, China.
Abstract:
Molecular glue degraders (MGDs) have emerged as promising therapeutic agents with substantial clinical potential and growing commercial interest in terms of their pharmaceutical development. Nevertheless, the translation of MGDs into clinical trials remains limited. Recent advances in drug discovery technologies are facilitating a paradigm shift in MGD development, from serendipitous discovery to rational design. Here, we systematically analyze rational MGD discovery strategies, focusing on E3 ligase and target ligand modifications. Furthermore, we highlight cutting-edge technologies and the latest trends in MGD development. Thus, this review provide valuable insights for researchers and could help accelerate the clinical translation of MGDs.

